Scopolamine
ATI-format individual drug card with NCLEX-focused assessment, safety, teaching, and source attribution.
Scopolamine
ATI class: Antiemetic / Anticholinergic
Action
- Blocks muscarinic receptors to reduce vestibular input to the vomiting center.
- Decreases parasympathetic stimulation and secretions.
Therapeutic use
- Motion sickness prevention
- Postoperative nausea and vomiting prevention
Nursing assessment
- Assess for anticholinergic effects: dry mouth, blurred vision, urinary retention, constipation, tachycardia, and confusion.
- Check glaucoma risk and urinary retention risk before use.
- Monitor older adults for confusion and falls.
Administration
- Transdermal patch
Side effects
- Dry mouth
- Drowsiness
- Blurred vision
- Constipation
Adverse effects
- Acute angle-closure glaucoma
- Urinary retention
- Confusion or hallucinations
Interactions
- Alcohol
- Sedatives
- Other anticholinergics
- Antihistamines
- Tricyclic antidepressants
Contraindications
- Narrow-angle glaucoma
- Hypersensitivity
Precautions
- Use caution with BPH, urinary retention, bowel obstruction risk, older adults, and cognitive impairment.
- Wash hands after applying or removing patch to avoid eye exposure.
Client teaching
- Apply behind the ear as directed and remove the old patch before applying a new one.
- Avoid touching eyes after handling the patch.
- Report eye pain, vision halos, inability to urinate, confusion, or severe dizziness.
Medication outcomes
- Reduced motion-related nausea
- Reduced postoperative nausea and vomiting
Antidote / rescue
- No routine antidote is seeded; severe anticholinergic toxicity requires urgent provider or poison-control guidance.
NCLEX priority cues
- Eye pain or halos after patch exposure can indicate angle-closure glaucoma.
- Confusion and urinary retention are not routine mild dry-mouth effects.
- Patch handling matters because accidental eye exposure is testable.
Medication classes
Source attribution
Related study cards
Shows the medication class, ATI cues, source references, and connected study cards for this drug.
Blocks parasympathetic activity, so secretions dry up, heart rate can rise, and smooth muscle spasms decrease.
Reduces nausea through different pathways, including serotonin, dopamine, histamine, muscarinic, cannabinoid, and NK1 receptor effects.
ATI medication adverse effect concept.
ATI medication interaction concept.
ATI medication class concept.
ATI medication class concept.
ATI medication interaction concept.
ATI medication client teaching concept.
ATI medication nursing assessment concept.
ATI medication client teaching concept.
ATI medication mechanism of action concept.
ATI medication side effect concept.